Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

IGM Biosciences, Inc. - Common Stock (NQ: IGMS )

1.880 -0.120 (-6.00%)
Streaming Delayed Price Updated: 1:10 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 266,672
Open 2.050
Bid (Size) 1.860 (2)
Ask (Size) 1.880 (3)
Prev. Close 2.000
Today's Range 1.811 - 2.059
52wk Range 1.590 - 22.50
Shares Outstanding 25,905,471
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Crude Oil Surges 3%; Delta Air Lines Posts Better-Than-Expected Earnings
Via Benzinga
Exposures Fossil Fuels
Nasdaq Down Over 2%; Walgreens Posts Upbeat Results
Via Benzinga

Performance

YTD
-69.73%
-69.73%
1 Month
-74.59%
-74.59%
3 Month
-86.73%
-86.73%
6 Month
-84.21%
-84.21%
1 Year
-80.27%
-80.27%

More News

Read More
Dow Dips 500 Points; US Economy Adds 256,000 Jobs In December
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
US Stocks To Open On A Tentative Note As Traders Remain Cautious Ahead Of Friday's Crucial Jobs Data
Via Benzinga
The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
Via Benzinga
What 4 Analyst Ratings Have To Say About IGM Biosciences
Via Benzinga
Why Zoomcar Shares Are Trading Higher By Over 40%; Here Are 20 Stocks Moving Premarket
Via Benzinga
IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Crude Oil Up 2%; Siyata Mobile Shares Jump
Via Benzinga
Exposures Fossil Fuels
Dow Dips Over 300 Points; Viad Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Government
Exposures Political
PepsiCo, DocuSign, Robinhood And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
IGM Biosciences' New Found Focus: Pivots From Cancer To Autoimmune Diseases, Names New CEO
Via Benzinga
Top 1% Biotech, IGM Biosciences, Plummets On Scrapped Drug, C-Suite Makeover
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
From IGM Biosciences, Inc.
Via GlobeNewswire
Russell 2000 Outpaces S&P 500 As Small Caps Anticipate Fed's Interest Rate Move
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
From IGM Biosciences, Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.